◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Medexus Pharmaceuticals Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q4 2025Dec 31, 2025 Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024
Total Revenue 25.3M 24.7M 24.6M 24.8M 30.0M
Operating Revenue 25.3M 24.7M 24.6M 24.8M 30.0M
Cost Of Revenue 11.7M 11.0M 10.8M 12.3M 14.8M
Gross Profit 13.6M 13.8M 13.8M 12.4M 15.2M
Selling General And Administration 9.3M 10.2M 10.5M 10.1M 9.4M
General And Administrative Expense 7.9M 8.3M 8.2M 8.7M 6.7M
Research And Development 2.5M 1.8M 2.4M 2.5M 2.0M
Depreciation And Amortization In Income Statement 70,000 72,000 70,000 77,000 60,000
Operating Expense 11.9M 12.1M 12.9M 12.7M 11.4M
Operating Income 1.7M 1.7M 850,000 -290,000 3.8M
EBIT 1.8M 1.1M 2.0M 1.2M 2.9M
Interest Expense 1.4M 1.4M 1.4M 2.0M 2.0M
Interest Expense Non Operating 1.4M 1.4M 1.4M 2.0M 2.0M
Net Interest Income -1.4M -1.4M -1.4M -2.0M -2.0M
Other Income Expense 132,000 -573,000 1.2M 1.5M -905,000
Special Income Charges 0.00 -276,000 590,000 1.6M 0.00
Restructuring And Mergern Acquisition 0.00 276,000 -182,000 -1.9M 0.00
Gain On Sale Of Security 132,000 -297,000 581,000 -65,000 -905,000
Pretax Income 446,000 -327,000 615,000 -759,000 880,000
Tax Provision 366,000 -12,000 99,000 -206,000 147,000
Tax Effect Of Unusual Items 19,800 -21,028 188,502 416,885 -151,176
Net Income From Continuing And Discontinued Operation 80,000 -315,000 516,000 -553,000 733,000
Net Income From Continuing Operation Net Minority Interest 80,000 -315,000 516,000 -553,000 733,000
Net Income Including Noncontrolling Interests 80,000 -315,000 516,000 -553,000 733,000
Net Income Common Stockholders 80,000 -315,000 516,000 -553,000 733,000
Net Income 80,000 -315,000 516,000 -553,000 733,000
EBITDA 4.2M 3.5M 4.4M 3.7M 4.6M
Normalized EBITDA 4.1M 4.1M 3.3M 2.1M 5.5M
Reconciled Depreciation 2.4M 2.4M 2.4M 2.4M 1.8M
Basic EPS 0.00 -0.01 0.02 -- 0.03
Diluted EPS 0.00 -0.01 0.02 -- 0.03
Basic Average Shares 32.4M 32.3M 32.3M -- 24.7M
Diluted Average Shares 33.4M 32.3M 32.3M -- 25.6M
Total Unusual Items 132,000 -573,000 1.2M 1.5M -905,000
Total Unusual Items Excluding Goodwill 132,000 -573,000 1.2M 1.5M -905,000
Tax Rate For Calcs 0.15 0.04 0.16 0.27 0.17
Normalized Income -32,200 236,972 -466,498 -1.7M 1.5M
Depreciation Amortization Depletion Income Statement 70,000 72,000 70,000 77,000 60,000
Depreciation Income Statement 70,000 72,000 70,000 77,000 60,000
Diluted NI Availto Com Stockholders 80,000 -315,000 516,000 -553,000 733,000
Gain On Sale Of Ppe 0.00 0.00 408,000 -- 0.00
Impairment Of Capital Assets 0.00 0.00 -- 338,000 0.00
Net Income Continuous Operations 80,000 -315,000 516,000 -553,000 733,000
Net Non Operating Interest Income Expense -1.4M -1.4M -1.4M -2.0M -2.0M
Other Gand A 1.5M 2.1M 1.6M 2.2M 1.3M
Reconciled Cost Of Revenue 9.4M 8.6M 8.5M 10.0M 13.1M
Salaries And Wages 6.4M 6.3M 6.6M 6.5M 5.5M
Selling And Marketing Expense 1.4M 1.9M 2.3M 1.5M 2.6M
Total Expenses 23.6M 23.1M 23.8M 25.0M 26.2M
Total Operating Income As Reported 1.7M 1.4M 850,000 -1.2M 3.8M
Line Item Q4 2025Dec 31, 2025 Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024
Cash And Cash Equivalents 15.0M 9.4M 9.3M 24.0M 8.4M
Cash Cash Equivalents And Short Term Investments 15.0M 9.4M 9.3M 24.0M 8.4M
Accounts Receivable 11.8M 12.0M 12.2M 13.2M 14.1M
Receivables 11.8M 12.1M 12.4M 13.3M 14.1M
Inventory 31.3M 34.2M 35.4M 35.3M 34.0M
Prepaid Assets -- -- -- 7.6M 9.8M
Other Current Assets 11.9M 6.7M 7.1M 376,000 369,000
Current Assets 70.0M 62.4M 64.2M 80.6M 66.7M
Gross PPE -- -- -- 2.0M 2.0M
Accumulated Depreciation -- -- -- -1.4M -1.3M
Net PPE 457,000 507,000 573,000 689,000 712,000
Goodwill 10.2M 10.1M 10.2M 10.0M 10.0M
Goodwill And Other Intangible Assets 75.0M 77.2M 79.8M 81.6M 69.3M
Other Intangible Assets 64.8M 67.1M 69.5M 71.6M 59.3M
Total Non Current Assets 85.0M 87.0M 89.6M 91.3M 79.3M
Total Assets 155.0M 149.4M 153.8M 171.8M 146.0M
Current Debt 7.2M 20.9M 21.7M 37.0M 17.7M
Current Debt And Capital Lease Obligation 7.2M 20.9M 21.7M 37.0M 17.7M
Accounts Payable 43.4M 37.7M 39.7M 5.7M 39.8M
Payables 55.2M 54.0M 57.2M 30.5M 46.0M
Payables And Accrued Expenses 55.2M 54.0M 57.2M 60.2M 46.0M
Current Accrued Expenses -- -- -- 29.7M --
Other Current Liabilities -- -- -- 125,000 2.6M
Current Liabilities 62.4M 74.9M 78.9M 97.3M 66.3M
Long Term Debt 18.2M 118,000 159,000 198,000 22.2M
Long Term Debt And Capital Lease Obligation 18.2M 118,000 159,000 198,000 22.2M
Total Non Current Liabilities Net Minority Interest 40.4M 22.1M 21.9M 22.4M 46.5M
Total Liabilities Net Minority Interest 102.8M 97.0M 100.8M 119.7M 112.9M
Common Stock 96.2M 96.4M 96.1M 96.1M 76.8M
Capital Stock 96.2M 96.4M 96.1M 96.1M 76.8M
Additional Paid In Capital 11.6M 11.7M 12.2M 12.0M 11.9M
Retained Earnings -61.7M -61.8M -61.5M -62.0M -61.4M
Gains Losses Not Affecting Retained Earnings 6.2M 6.1M 6.2M 6.0M 5.9M
Common Stock Equity 52.2M 52.4M 53.0M 52.1M 33.1M
Stockholders Equity 52.2M 52.4M 53.0M 52.1M 33.1M
Total Equity Gross Minority Interest 52.2M 52.4M 53.0M 52.1M 33.1M
Total Capitalization 70.4M 52.5M 53.1M 52.3M 55.3M
Net Tangible Assets -22.8M -24.8M -26.8M -29.5M -36.2M
Tangible Book Value -22.8M -24.8M -26.8M -29.5M -36.2M
Working Capital 7.6M -12.5M -14.7M -16.7M 368,000
Invested Capital 77.6M 73.5M 74.9M 89.3M 73.0M
Total Debt 25.4M 21.1M 21.9M 37.2M 39.9M
Net Debt 10.4M 11.7M 12.6M 13.2M 31.5M
Share Issued 32.4M 32.4M 32.3M 32.3M 24.7M
Ordinary Shares Number 32.4M 32.4M 32.3M 32.3M 24.7M
Allowance For Doubtful Accounts Receivable -639,000 -664,000 -801,000 -801,000 --
Buildings And Improvements -- -- -- 781,000 775,000
Finished Goods -- -- -- 14.8M --
Foreign Currency Translation Adjustments 6.2M 6.1M 6.2M 6.0M 5.9M
Gross Accounts Receivable 12.4M 12.7M 13.0M 14.0M --
Income Tax Payable 2.3M 1.8M 1.7M 1.4M 1.7M
Machinery Furniture Equipment -- -- -- 1.3M 1.2M
Non Current Deferred Assets 9.6M 9.3M 9.2M 9.0M 9.3M
Non Current Deferred Taxes Assets 9.6M 9.3M 9.2M 9.0M 9.3M
Other Current Borrowings 7.2M 20.9M 21.7M 37.0M --
Other Payable 9.5M 14.6M 15.7M 23.4M 4.5M
Other Properties -- -- -- -- 775,000
Properties -- -- -- 0.00 0.00
Raw Materials -- -- -- 1.5M --
Taxes Receivable 66,000 54,000 148,000 136,000 --
Total Tax Payable 2.3M 1.8M 1.7M 1.4M 1.7M
Tradeand Other Payables Non Current 22.2M 22.0M 21.8M 22.2M 24.4M
Work In Process -- -- -- 19.0M --
Line Item Q4 2025Dec 31, 2025 Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024
Operating Cash Flow 7.8M 3.3M 3.9M 2.3M 6.7M
Cash Flow From Continuing Operating Activities 7.8M 3.3M 3.9M 2.3M 6.7M
Depreciation And Amortization 2.4M 2.4M 2.4M 2.4M 1.8M
Depreciation Amortization Depletion 2.4M 2.4M 2.4M 2.4M 1.8M
Stock Based Compensation -6,000 -122,000 167,000 116,000 7,000
Deferred Tax 366,000 -12,000 99,000 -206,000 147,000
Deferred Income Tax 366,000 -12,000 99,000 -206,000 147,000
Change In Working Capital 3.8M -290,000 580,000 619,000 1.3M
Changes In Account Receivables 289,000 244,000 1.1M 799,000 -1.2M
Change In Receivables 289,000 244,000 1.1M 799,000 -1.2M
Change In Inventory 1.0M 2.7M -476,000 -344,000 4.0M
Change In Payables And Accrued Expense 7.6M -3.6M -913,000 535,000 2.7M
Change In Other Current Assets -- -- -18,000 -8,000 19,000
Other Non Cash Items 1.4M 1.4M 1.2M -475,000 2.0M
Capital Expenditure -19,000 -7,000 -125,000 -53,000 -104,000
Purchase Of PPE -19,000 -7,000 -125,000 -53,000 -61,000
Net PPE Purchase And Sale -19,000 -7,000 -125,000 -53,000 -61,000
Purchase Of Business -407,000 -1.6M -369,000 -2.0M -375,000
Investing Cash Flow -5.4M -1.7M -2.3M -2.1M -479,000
Cash Flow From Continuing Investing Activities -5.4M -1.7M -2.3M -2.1M -479,000
Issuance Of Debt 25.6M -- -- 0.00 0.00
Repayment Of Debt -21.5M -1.2M -15.6M -3.4M -3.4M
Net Issuance Payments Of Debt 4.0M -1.2M -15.6M -3.4M -3.4M
Issuance Of Capital Stock -- -- -- 19.2M 0.00
Repurchase Of Capital Stock -375,000 -- -- -- 0.00
Net Common Stock Issuance -375,000 -- -- 19.2M 0.00
Common Stock Payments -375,000 -- -- -- 0.00
Financing Cash Flow 3.1M -1.6M -16.3M 15.2M -4.5M
Cash Flow From Continuing Financing Activities 3.1M -1.6M -16.3M 15.2M -4.5M
Effect Of Exchange Rate Changes 47,000 -34,000 72,000 153,000 -302,000
Changes In Cash 5.5M 83,000 -14.7M 15.4M 1.8M
Beginning Cash Position 9.4M 9.3M 24.0M 8.4M 7.0M
End Cash Position 15.0M 9.4M 9.3M 24.0M 8.4M
Free Cash Flow 7.8M 3.3M 3.8M 2.2M 6.6M
Amortization Cash Flow 2.4M 2.4M 2.4M 2.4M 1.7M
Amortization Of Intangibles 2.4M 2.4M 2.4M 2.4M 1.7M
Asset Impairment Charge 0.00 0.00 -- 338,000 0.00
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00
Change In Prepaid Assets -5.1M 380,000 910,000 2.1M -4.1M
Common Stock Issuance -- -- -- 19.2M 0.00
Depreciation 70,000 72,000 70,000 77,000 60,000
Gain Loss On Investment Securities -- -- -182,000 -- --
Interest Paid Cff -516,000 -442,000 -739,000 -779,000 -1.1M
Long Term Debt Issuance 25.6M -- -- 0.00 0.00
Long Term Debt Payments -21.5M -1.2M -15.6M -3.4M -3.4M
Net Business Purchase And Sale -407,000 -1.6M -369,000 -2.0M -375,000
Net Foreign Currency Exchange Gain Loss -194,000 248,000 -675,000 -10,000 924,000
Net Income From Continuing Operations 80,000 -315,000 516,000 -553,000 733,000
Net Intangibles Purchase And Sale 0.00 -- -- 0.00 -43,000
Net Long Term Debt Issuance 4.0M -1.2M -15.6M -3.4M -3.4M
Net Other Investing Changes -5.0M -- -1.8M -- --
Net Short Term Debt Issuance -- -- -- 0.00 0.00
Operating Gains Losses -194,000 248,000 -1.1M -10,000 924,000
Purchase Of Intangibles 0.00 -- -- 0.00 -43,000
Short Term Debt Payments -- -- -- 0.00 0.00
Taxes Refund Paid -47,000 -7,000 -10,000 11,000 -147,000
NEWS
Loading news...
TRENDING
Loading...